Clinical Trial Update: A Study of Solifenacin Succinate Compared to Tolterodine in Patients With Overactive Bladder [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing solifenacin succinate with tolterodine for overactive bladder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Solifenacin succinate (solifenacin)
• Tolterodine (tolterodine)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Overactive Bladder | Phase 3 | Status: COMPLETED